People's Insurance Company (Group) of China Valuation
Is 1339 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 1339 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 1339 (HK$3.83) is trading below our estimate of fair value (HK$18.01)
Significantly Below Fair Value: 1339 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1339?
Key metric: As 1339 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 1339's PE Ratio? | |
|---|---|
| PE Ratio | 4.1x |
| Earnings | CN¥38.15b |
| Market Cap | CN¥293.19b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.9x |
| Enterprise Value/EBITDA | 7.6x |
| PEG Ratio | -2x |
Price to Earnings Ratio vs Peers
How does 1339's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 10x | ||
2328 PICC Property and Casualty | 11x | 11.1% | HK$270.9b |
2628 China Life Insurance | 4.7x | -14.5% | HK$1.1t |
1299 AIA Group | 16.5x | 13.9% | HK$619.5b |
6963 Sunshine Insurance Group | 7.6x | 17.0% | HK$32.8b |
1339 People's Insurance Company (Group) of China | 4.1x | -2.1% | HK$315.3b |
Price-To-Earnings vs Peers: 1339 is good value based on its Price-To-Earnings Ratio (4.1x) compared to the peer average (10x).
Price to Earnings Ratio vs Industry
How does 1339's PE Ratio compare vs other companies in the Asian Insurance Industry?
| 6 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 6 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 1339 is good value based on its Price-To-Earnings Ratio (4.1x) compared to the Asian Insurance industry average (11x).
Price to Earnings Ratio vs Fair Ratio
What is 1339's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 4.1x |
| Fair PE Ratio | 8.8x |
Price-To-Earnings vs Fair Ratio: 1339 is good value based on its Price-To-Earnings Ratio (4.1x) compared to the estimated Fair Price-To-Earnings Ratio (8.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | HK$3.83 | HK$4.24 +10.7% | 14.9% | HK$5.89 | HK$3.23 | n/a | 15 |
| Nov ’25 | HK$3.95 | HK$4.09 +3.5% | 9.2% | HK$4.90 | HK$3.28 | n/a | 15 |
| Oct ’25 | HK$3.71 | HK$3.61 -2.7% | 14.7% | HK$4.23 | HK$2.53 | n/a | 15 |
| Sep ’25 | HK$2.95 | HK$3.40 +15.3% | 15.1% | HK$4.20 | HK$2.52 | n/a | 15 |
| Aug ’25 | HK$2.63 | HK$3.34 +27.1% | 15.3% | HK$4.31 | HK$2.48 | n/a | 15 |
| Jul ’25 | HK$2.68 | HK$3.36 +25.4% | 14.3% | HK$4.28 | HK$2.46 | n/a | 17 |
| Jun ’25 | HK$2.72 | HK$3.36 +23.4% | 14.1% | HK$4.29 | HK$2.47 | n/a | 18 |
| May ’25 | HK$2.58 | HK$3.28 +27.1% | 13.9% | HK$4.30 | HK$2.47 | n/a | 17 |
| Apr ’25 | HK$2.50 | HK$3.28 +31.2% | 14.4% | HK$4.30 | HK$2.48 | n/a | 16 |
| Mar ’25 | HK$2.64 | HK$3.22 +22.0% | 15.1% | HK$4.06 | HK$2.29 | n/a | 15 |
| Feb ’25 | HK$2.47 | HK$3.26 +31.8% | 16.3% | HK$4.15 | HK$2.28 | n/a | 15 |
| Jan ’25 | HK$2.40 | HK$3.46 +44.3% | 17.6% | HK$4.97 | HK$2.31 | n/a | 16 |
| Dec ’24 | HK$2.51 | HK$3.45 +37.6% | 17.4% | HK$4.95 | HK$2.32 | n/a | 16 |
| Nov ’24 | HK$2.59 | HK$3.41 +31.6% | 17.7% | HK$4.83 | HK$2.27 | HK$3.95 | 14 |
| Oct ’24 | HK$2.81 | HK$3.47 +23.3% | 17.1% | HK$4.85 | HK$2.27 | HK$3.71 | 14 |
| Sep ’24 | HK$2.67 | HK$3.45 +29.0% | 17.7% | HK$4.88 | HK$2.29 | HK$2.95 | 16 |
| Aug ’24 | HK$2.91 | HK$3.33 +14.4% | 18.7% | HK$4.92 | HK$2.22 | HK$2.63 | 18 |
| Jul ’24 | HK$2.84 | HK$3.37 +18.6% | 18.7% | HK$5.00 | HK$2.26 | HK$2.68 | 18 |
| Jun ’24 | HK$2.95 | HK$3.32 +12.5% | 16.4% | HK$4.34 | HK$2.25 | HK$2.72 | 18 |
| May ’24 | HK$3.08 | HK$3.30 +7.2% | 16.4% | HK$4.47 | HK$2.29 | HK$2.58 | 17 |
| Apr ’24 | HK$2.62 | HK$3.22 +23.1% | 18.3% | HK$4.50 | HK$2.27 | HK$2.50 | 17 |
| Mar ’24 | HK$2.55 | HK$3.23 +26.8% | 19.9% | HK$4.42 | HK$2.25 | HK$2.64 | 18 |
| Feb ’24 | HK$2.67 | HK$3.29 +23.1% | 18.9% | HK$4.51 | HK$2.29 | HK$2.47 | 18 |
| Jan ’24 | HK$2.59 | HK$3.21 +23.9% | 15.0% | HK$3.95 | HK$2.50 | HK$2.40 | 16 |
| Dec ’23 | HK$2.52 | HK$3.07 +21.8% | 16.1% | HK$3.84 | HK$2.36 | HK$2.51 | 17 |
| Nov ’23 | HK$2.22 | HK$3.02 +36.1% | 16.2% | HK$3.86 | HK$2.33 | HK$2.59 | 18 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
China Life Insurance
HK$1.1t
Operates as a life insurance company in the People’s Republic of China.
2628
HK$15.60
7D
-0.5%
1Y
39.5%
People's Insurance Company (Group) of China
HK$316.5b
An investment holding company, provides insurance products and services in the People’s Republic of China and Hong Kong.
1339
HK$3.90
7D
-5.3%
1Y
49.4%
China Taiping Insurance Holdings
HK$45.1b
An investment holding company, underwrites various insurance and reinsurance products in the People’s Republic of China, Hong Kong, Macau, Singapore, and internationally.
966
HK$12.54
7D
-4.6%
1Y
72.3%